SpyGlass Pharma, Inc.
SGP
$26.20
$1.034.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -19.86M | -13.82M | -12.56M | -8.68M | |
| Total Depreciation and Amortization | 342.00K | 318.00K | 216.70K | 134.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 2.21M | 1.71M | 443.40K | 692.00K | |
| Change in Net Operating Assets | 2.48M | -1.75M | 2.56M | 1.52M | |
| Cash from Operations | -14.84M | -13.54M | -9.33M | -6.33M | |
| Capital Expenditure | -1.93M | -676.00K | -420.50K | -52.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 999.00K | -991.00K | 995.20K | -- | |
| Cash from Investing | -933.00K | -1.67M | 574.70K | -52.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 31.00K | 55.00K | 19.80K | 11.00K | |
| Repurchase of Common Stock | -- | -- | 0.00 | -1.45M | |
| Issuance of Preferred Stock | 0.00 | 160.43M | 300.00 | 77.33M | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -18.00K | -2.73M | -909.80K | -274.00K | |
| Cash from Financing | 13.00K | 157.76M | -889.60K | 75.61M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -15.76M | 142.54M | -9.65M | 69.24M | |